EGFR and ovarian cancer: The synergistic oncogenic network formed by ZKSCAN3 with EGFR in ovarian cancer reveals a unique mechanism for remodeling the microenvironment through receptor tyrosine kinase signaling in solid tumors, and its functional studies in multiple myeloma further broaden its scope of action.